Literature DB >> 13513912

Studies on the activation of a proesterase associated with partially purified first component of human complement.

I H LEPOW, O D RATNOFF, L R LEVY.   

Abstract

It has been found that under a wide range of physico-chemical conditions a positive correlation exists between the rate of disappearance of hemolytically active, partially purified first component of human complement and the rate of activation of an esterase hydrolyzing N-acetyl-L-tyrosine ethyl ester. Both reactions follow the kinetic equation for second order autocatalysis, with an apparent energy of activation of 31,000 calories per mol. They occur optimally at pH 7.3-7.7 and are inhibited by ionic strengths greater than 0.15, by 5 x 10(5)M ethylenediaminetetraacetic acid, and by a heat-labile serum inhibitor which appears unrelated to any component of complement. The activation of first component to esterase resembles closely the activation of trypsinogen to trypsin. Partially purified first component, containing plasminogen, may also be activated to esterase by addition of streptokinase. The significance of these data with respect to the postulated existence of first component as a proesterase and its possible role in complement-"fixation" is discussed.

Entities:  

Keywords:  COMPLEMENT; ESTERASES

Mesh:

Substances:

Year:  1958        PMID: 13513912      PMCID: PMC2136687          DOI: 10.1084/jem.107.3.451

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  12 in total

1.  A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma.

Authors:  O D RATNOFF; J E COLOPY
Journal:  J Clin Invest       Date:  1955-04       Impact factor: 14.808

2.  Inhibition of immune hemolysis by diisopropyl fluorophosphate.

Authors:  L LEVINE
Journal:  Biochim Biophys Acta       Date:  1955-10

3.  Concerning the mechanism of complement action. I. Inhibition of complement activity by diisopropyl fluophosphate.

Authors:  E L BECKER
Journal:  J Immunol       Date:  1956-12       Impact factor: 5.422

4.  Studies on the mechanism of inactivation of human complement by plasmin and by antigen-antibody aggregates. I. The requirement for a factor resembling C'1 and the role of Ca++.

Authors:  I H LEPOW; L WURZ; O D RATNOFF; L PILLEMER
Journal:  J Immunol       Date:  1954-09       Impact factor: 5.422

5.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

6.  The action of plasmin on synthetic substrates.

Authors:  W TROLL; S SHERRY; J WACHMAN
Journal:  J Biol Chem       Date:  1954-05       Impact factor: 5.157

7.  Plasma thromboplastin component (PTC) deficiency; a new disease resembling hemophilia.

Authors:  P M AGGELER; S G WHITE; M B GLENDENING; E W PAGE; T B LEAKE; G BATES
Journal:  Proc Soc Exp Biol Med       Date:  1952-04

8.  The influence of calcium ions on the inactivation of human complement and its components by plasmin.

Authors:  I H LEPOW; L PILLEMER; O D RATNOFF
Journal:  J Exp Med       Date:  1953-09       Impact factor: 14.307

9.  Some properties of an esterase derived from preparations of the first component of complement.

Authors:  O D RATNOFF; I H LEPOW
Journal:  J Exp Med       Date:  1957-08-01       Impact factor: 14.307

10.  A COMPARISON OF HUMAN AND GUINEA PIG COMPLEMENTS AND THEIR COMPONENT FRACTIONS.

Authors:  O G Bier; G Leyton; M M Mayer; M Heidelberger
Journal:  J Exp Med       Date:  1945-05-01       Impact factor: 14.307

View more
  31 in total

1.  ACTION OF COMPLEMENT IN HEREDITARY ANGIONEUROTIC EDEMA: THE ROLE OF C'1-ESTERASE.

Authors:  V H DONALDSON; F S ROSEN
Journal:  J Clin Invest       Date:  1964-11       Impact factor: 14.808

2.  [Methodological and clinical studies on the properdin system. III. Studies on the behavior of 4 complement components after major gynecological operations].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Arch Gynakol       Date:  1961

3.  Studies on the activation of a serum esterase with ether and its relationship to C'l-esterase.

Authors:  V H DONALDSON
Journal:  J Clin Invest       Date:  1961-04       Impact factor: 14.808

4.  TAMe esterase activity of guinea-pig serum. II. Peptone inducible esterases.

Authors:  E L BECKER; K F AUSTEN; D M MARCUS
Journal:  Br J Exp Pathol       Date:  1959-10

5.  Complement components in three pathological sera: relation to clinical states.

Authors:  A B Laurell; B Lundh; J Malmquist; R Siboo
Journal:  Clin Exp Immunol       Date:  1966-01       Impact factor: 4.330

6.  The diphasic effects of proteases on serum complement.

Authors:  I Innerfield
Journal:  Agents Actions       Date:  1974-08

7.  Conversion of the fourth complement component studied by crossed immunoelectrophoresis.

Authors:  A G Sjöholm; A B Laurell
Journal:  Clin Exp Immunol       Date:  1973-08       Impact factor: 4.330

Review 8.  Participation of components of the blood coagulation system in the inflammatory response.

Authors:  D G McKay
Journal:  Am J Pathol       Date:  1972-04       Impact factor: 4.307

9.  Structural polymorphism of the fourth component of human complement.

Authors:  S I Rosenfeld; S Ruddy; K F Austen
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

10.  C1 inactivator inhibition by plasmin.

Authors:  P C Harpel
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.